Presentation
Céline BANAL
Céline Banal is an engineer. After graduating and four years at the Necker DNA biobank, she joined the iPS platform in January 2017.
She reprograms somatic cells (blood cells, fibroblasts) into pluripotent stem cells (iPS) and it ensures their molecular and functional characterization. She is also involved in research projects aiming to differentiate iPS lines into 2D cells (neural stem cells, mesenchymal stem cells) and 3D structures (intestinal organoids, cerebral organoids).
Resources & publications
-
Journal (source)J. Bone Miner. Res.
Fgfr3 Is a Positive Regulator of Osteoblast Expansion and Differentiation Dur...
-
Journal (source)Neurochirurgie
Animal models of craniosynostosis.
-
Journal (source)Hum. Mol. Genet.
Constitutively-active FGFR3 disrupts primary cilium length and IFT20 traffick...
-
Journal (source)Dev. Dyn.
Achondroplasia: Development, pathogenesis, and therapy.
-
Journal (source)Bone. 2020 Dec
Novel therapeutic approaches for the treatment of achondroplasia.
-
Journal (source)J Clin Invest
Tyrosine kinase inhibitor NVP-BGJ398 functionally improves FGFR3-related dwar...
-
Journal (source)Hum Mol Genet
An activating Fgfr3 mutation affects trabecular bone formation via a paracrin...
-
Journal (source)JCI Insight
Phosphatase inhibition by LB-100 enhances BMN-111 stimulation of bone growth.